𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimizing the CAMCOG test in the screening for mild cognitive impairment and incipient dementia: saving time with relevant domains

✍ Scribed by Ivan Aprahamian; Breno Satler Diniz; Rafael Izbicki; Márcia Radanovic; Paula Villela Nunes; Orestes Vicente Forlenza


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
113 KB
Volume
26
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


To identify the CAMCOG sub-items that best contribute for the identification of patients with mild cognitive impairment (MCI) and incipient Alzheimer's disease (AD) in clinical practice. Methods: Cross-sectional assessment of 272 older adults (98 MCI, 82 AD, and 92 controls) with a standardized neuropsychological battery and the CAMCOG schedule. Backward logistic regression analysis with diagnosis (MCI and controls) as dependent variable and the sub-items of the CAMCOG as independent variable was carried out to determine the CAMCOG sub-items that predicted the diagnosis of MCI. Results: Lower scores on Language, Memory, Praxis, and Calculation CAMCOG sub-items were significantly associated with the diagnosis of MCI. A composite score obtained by the sum of these scores significantly discriminated MCI patients from comparison groups. This reduced version of the CAMCOG showed similar diagnostic accuracy than the original schedule for the identification of patients with MCI as compared to controls (AUC ¼ 0.80 AE 0.03 for the reduced CAMCOG; AUC ¼ 0.79 AE 0.03 for the original CAMCOG). Conclusion: This reduced version of the CAMCOG had similar diagnostic properties as the original CAMCOG and was faster and easier to administer, rendering it more suitable for the screening of subtle cognitive deficits in general clinical practice.


📜 SIMILAR VOLUMES


Screening for amnestic mild cognitive im
✍ L. Rami; J. L. Molinuevo; R. Sanchez-Valle; B. Bosch; A. Villar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

## Abstract ## Objectives To design and validate a new screening test for amnestic Mild Cognitive Impairment (A‐MCI) and early stage Alzheimer's disease (AD). ## Methods We develop a verbal episodic and semantic memory test: the Memory Alteration Test (M@T). Discriminative validity was assessed